World's first drug for treatment of Non-Cirrhotic NASH approved: Zydus Medical Dialogues Bureau6 March 2020 8:56 AM GMTSaroglitazar is uniquely poised with its dual PPAR alpha and gamma properties – reducing the comorbidities (dyslipidemia, hypertriglyceridemia,...